Skip to content
TrialScanner

NCT02653300

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Phase 2CompletedORMPLead

Registry record

Lead sponsor
Oramed, Ltd.
Conditions
Non-Alcoholic Steatohepatitis (NASH); Type2 Diabetes Mellitus
Primary completion
Mar 1, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02653300 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02653300: A Pilot Study to Assess the... | TrialScanner